RT null
T1 Recommendations for the Diagnosis and Management of Asbestos-related Pleural and Pulmonary Disease
A1 Diego Roza, Carmen
A1 Cruz Carmona, M Jesús
A1 Fernández Álvarez, Ramón
A1 Ferrer Sancho, Jaume
A1 Marín Martínez, Belén
A1 Martínez González, Cristina
A1 Rodríguez Portal, José Antonio
A1 Romero Valero, Fernando
A1 Villena Garrido, María Victoria
AB Asbestos is the term used for a set of mineral silicates that tend to break up into fibers. Its use has been associated with numerous diseases affecting the lung and pleura in particular, all of which are characterized by their long period of latency. Asbestos, moreover, has been recognized by the WHO as a Group IA carcinogen since 1987 and its use was banned in Spain in 2002. The publication in 2013 of the 3rd edition of the specific asbestos health monitoring protocol, together with the development of new diagnostic techniques, prompted the SEPAR EROM group to sponsor publication of guidelines, which review the clinical, radiological and functional aspects of the different asbestos-related diseases. Recommendations have also been made for the diagnosis and follow-up of exposed patients. These recommendations were drawn up in accordance with the GRADE classification system.
PB Elsevier
SN 1579-2129
YR 2017
FD 2017-08-01
LK https://hdl.handle.net/20.500.14352/122944
UL https://hdl.handle.net/20.500.14352/122944
LA eng
NO Roza CD, Cruz Carmona MJ, Álvarez RF, Sancho JF, Martínez BM, González CM, et al. Recomendaciones sobre el diagnóstico y manejo de la enfermedad pleural y pulmonar por asbesto. Arch Bronconeumol. 2017;53:437–442.
DS Docta Complutense
RD 17 dic 2025